174 related articles for article (PubMed ID: 25069863)
1. A late, solitary brain metastasis of epithelial ovarian carcinoma.
Longo R; Platini C; Eid N; Elias-Matta C; Buda T; 'Nguyen D; Quétin P
BMC Cancer; 2014 Jul; 14():543. PubMed ID: 25069863
[TBL] [Abstract][Full Text] [Related]
2. Brain metastases in women with epithelial ovarian cancer: multimodal treatment including surgery or gamma-knife radiation is associated with prolonged survival.
Niu X; Rajanbabu A; Delisle M; Peng F; Vijaykumar DK; Pavithran K; Feng Y; Lau S; Gotlieb WH; Press JZ
J Obstet Gynaecol Can; 2013 Sep; 35(9):816-822. PubMed ID: 24099447
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncology.
Seber S; Turkmen E; Harputoğlu H; Yeşil H; Arpacι E; Menekşe S; Pilancι K; Oruç Z; Taskoylu BY; Gumusay O; Aksoy A; Karaagac M; Ozarslan E; Yetisyigit T
Eur J Gynaecol Oncol; 2017; 38(2):227-231. PubMed ID: 29953785
[TBL] [Abstract][Full Text] [Related]
4. Seven cases of epithelial ovarian carcinoma with brain metastasis.
Yang JX; Shen K; Shan Y; Lang JH; Wu M; Guo LN; Huang HF; Pan LY
Chin Med Sci J; 2008 Mar; 23(1):19-22. PubMed ID: 18437905
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases in epithelial ovarian and primary peritoneal carcinoma.
Ratner ES; Toy E; O'Malley DM; McAlpine J; Rutherford TJ; Azodi M; Higgins SA; Schwartz PE
Int J Gynecol Cancer; 2009 Jul; 19(5):856-9. PubMed ID: 19574773
[TBL] [Abstract][Full Text] [Related]
6. Management of brain metastasis in a patient with advanced epithelial ovarian carcinoma by gamma-knife radiosurgery.
Nikolaoul M; Stamenković S; Stergiou C; Skarleas C; Torrens M
Srp Arh Celok Lek; 2015; 143(3-4):205-9. PubMed ID: 26012133
[TBL] [Abstract][Full Text] [Related]
7. Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.
Liu BL; Liu SJ; Baskys A; Cheng H; Han Y; Xie C; Song H; Li J; Xin XY
BMC Cancer; 2014 Nov; 14():829. PubMed ID: 25399490
[TBL] [Abstract][Full Text] [Related]
8. Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
Fruscio R; Sina F; Dolci C; Signorelli M; Crivellaro C; Dell'Anna T; Cuzzocrea M; Guerra L; Milani R; Messa C
Gynecol Oncol; 2013 Dec; 131(3):689-93. PubMed ID: 24076062
[TBL] [Abstract][Full Text] [Related]
9. Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Pectasides D; Aravantinos G; Fountzilas G; Kalofonos C; Efstathiou E; Karina M; Pavlidis N; Farmakis D; Economopoulos T; Dimopoulos MA
Anticancer Res; 2005; 25(5):3553-8. PubMed ID: 16101179
[TBL] [Abstract][Full Text] [Related]
10. Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
García-Sáenz JA; Custodio A; Casado A; Vidart JA; Coronado PJ; Martín M; López-Tarruella S; Puente J; Fernández C; Díaz-Rubio E
Clin Transl Oncol; 2011 Feb; 13(2):121-32. PubMed ID: 21324801
[TBL] [Abstract][Full Text] [Related]
11. Management of brain metastases.
Soffietti R; Rudā R; Mutani R
J Neurol; 2002 Oct; 249(10):1357-69. PubMed ID: 12382150
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.
Deraco M; Kusamura S; Virzì S; Puccio F; Macrì A; Famulari C; Solazzo M; Bonomi S; Iusco DR; Baratti D
Gynecol Oncol; 2011 Aug; 122(2):215-20. PubMed ID: 21665254
[TBL] [Abstract][Full Text] [Related]
13. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
Elzarkaa AA; Sabaa BE; Abdelkhalik D; Mansour H; Melis M; Shaalan W; Farouk M; Malik E; Soliman AA
J Cancer Res Clin Oncol; 2016 May; 142(5):949-58. PubMed ID: 26762850
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.
Petrillo M; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Vizzielli G; Pedone Anchora L; Nero C; Margariti PA; Scambia G
Gynecol Oncol; 2013 Oct; 131(1):36-41. PubMed ID: 23791829
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy.
Kastritis E; Efstathiou E; Gika D; Bozas G; Koutsoukou V; Papadimitriou C; Pissakas G; Dimopoulos MA; Bamias A
Int J Gynecol Cancer; 2006; 16(3):994-9. PubMed ID: 16803475
[TBL] [Abstract][Full Text] [Related]
17. Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC).
Seifert H; Georgiou A; Alexander H; McLachlan J; Bodla S; Kaye S; Barton D; Nobbenhuis M; Gore M; Banerjee S
Gynecol Oncol; 2015 Nov; 139(2):216-20. PubMed ID: 26318078
[TBL] [Abstract][Full Text] [Related]
18. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
19. Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19).
Marchetti C; Ferrandina G; Cormio G; Gambino A; Cecere S; Lorusso D; De Giorgi U; Bogliolo S; Fagotti A; Mammoliti S; Narducci F; Bergamini A; Scollo P; Biglia N; Breda E; Tamberi S; Marinaccio M; Angioli R; Salerno L; Eusebi MC; Loizzi V; Scambia G; Panici PB
Gynecol Oncol; 2016 Dec; 143(3):532-538. PubMed ID: 27717490
[TBL] [Abstract][Full Text] [Related]
20. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
